v3.24.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities    
Net Loss $ (1,796,304) $ (2,276,821)
Adjustments to reconcile change in net loss to net cash used in operating activities:    
Depreciation and amortization 292,025 362,340
Stock-based compensation expense 88,232 97,879
Value of common stock issued in exchange for consulting services 71,940
Changes in operating assets and liabilities which used cash:    
Accounts Receivable 15,000 (90,440)
Prepaid expenses and other current assets (87,421) 298,860
Accounts payable (5,244) (9,422)
Accrued compensation (25,400) (137,856)
Deferred revenue (40,833) (65,932)
Accrued and other liabilities (17,887) (87,110)
Net cash and cash equivalents used in operating activities (1,577,832) (1,836,562)
Cash Flows from Investing Activities    
Purchase of property and equipment (1,166) (2,861)
Investment in capitalized software (118,200) (175,209)
Net cash and cash equivalents used in investing activities (119,366) (178,070)
Cash flows from Financing Activity    
Issuance of common stock - net of issuance costs 1,850,501
Net cash and cash equivalents provided by financing activity 1,850,501
Net decrease in cash and cash equivalents (1,697,198) (164,131)
Cash and cash equivalents - Beginning of period 5,360,661 7,155,367
Cash and cash equivalents - End of period $ 3,663,463 $ 6,991,236

Source